Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/110356
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorBerbís, Manuel Álvaro-
dc.contributor.authorSánchez-Puelles, José María-
dc.contributor.authorCañada, F. Javier-
dc.contributor.authorJiménez-Barbero, Jesús-
dc.date.accessioned2015-02-06T13:27:14Z-
dc.date.available2015-02-06T13:27:14Z-
dc.date.issued2015-01-14-
dc.identifier.citationCurrent Medicinal Chemistry 22 (14)1687-97 (2015)es_ES
dc.identifier.issn0929-8673-
dc.identifier.urihttp://hdl.handle.net/10261/110356-
dc.description24 p.-9 fig.es_ES
dc.description.abstractUDP-glucose is an essential metabolite for a variety of processes in the cell physiology in all organisms. In prokaryotes, it is involved in the synthesis of trehalose, an osmoprotectant, in galactose utilization via the Leloir pathway and it plays a key role in the synthesis of the components of the bacterial envelope, particularly the lipopolysaccharide and the capsule, which represent necessary virulence factors of many bacterial pathogens. UDP-glucose is synthesized in bacteria by the prokaryotic UDP-glucose pyrophosphorylase (UGP, EC 2.7.7.9), an enzyme belonging to the family of sugar:nucleotidyl transferases. Despite the ubiquitous distribution of UGP activity in all domains of life, prokaryotic UGPs are evolutionarily unrelated to their eukaryotic counterparts. Taken together, these features make of bacterial UGP an attractive target candidate for the discovery and development of new generation antibiotics. This review summarizes the current knowledge on structure and function of bacterial UGPs, underlying their potential as drug target candidates.es_ES
dc.description.sponsorshipWe thank MINECO for financial support (Grant CTQ 2012-32025, AES12/PI12/01628), EU for funding through the GlycoHit, ITN-Glycopharm, FP7-HEALTH-2012-INNOVATION-1, project number: 305483 and COST actions BM1003 and CM1102, as well as Comunidad de Madrid for the MHit project. MAB acknowledges a FPI fellowship from MINECO.es_ES
dc.language.isoenges_ES
dc.publisherBentham Science Publisherses_ES
dc.relation.isversionofPostprintes_ES
dc.rightsopenAccessen_EN
dc.subjectUGPes_ES
dc.subjectGalUes_ES
dc.subjectDrug targetes_ES
dc.subjectDrug discoveryes_ES
dc.subjectGlycosyltransferasees_ES
dc.subjectAntibioticses_ES
dc.titleStructure and function of prokaryotic UDP-glucose pyrophosphorylase, a drug target candidatees_ES
dc.typeartículoes_ES
dc.identifier.doi10.2174/0929867322666150114151248-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://dx.doi.org/10.2174/0929867322666150114151248-
dc.identifier.e-issn1875-533X-
dc.embargo.terms2016-01-14es_ES
dc.relation.csices_ES
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
item.cerifentitytypePublications-
item.openairetypeartículo-
item.languageiso639-1en-
item.grantfulltextopen-
Aparece en las colecciones: (CIB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Berbis et al_CurrMedChem 2014.pdf970,13 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

SCOPUSTM   
Citations

29
checked on 17-abr-2024

WEB OF SCIENCETM
Citations

29
checked on 25-feb-2024

Page view(s)

676
checked on 19-abr-2024

Download(s)

1.223
checked on 19-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.